XML 47 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
Fair value measurements (Tables)
9 Months Ended
Sep. 30, 2015
Fair Value Disclosures [Abstract]  
Financial Instruments Measured At Fair Value On A Recurring Basis
September 30, 2015
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
1,919

 
$
966

 
$
—

 
$
2,885

Foreign
—

 
14,238

 
53

 
14,291

Corporate securities
—

 
16,709

 
183

 
16,892

Mortgage-backed securities
—

 
11,065

 
54

 
11,119

States, municipalities, and political subdivisions
—

 
3,091

 
—

 
3,091

 
1,919

 
46,069

 
290

 
48,278

Equity securities
455

 
5

 
4

 
464

Short-term investments
703

 
1,105

 
—

 
1,808

Other investments (1)
314

 
218

 
209

 
741

Securities lending collateral
—

 
1,011

 
—

 
1,011

Investment derivative instruments
17

 
—

 
—

 
17

Other derivative instruments
26

 
—

 
—

 
26

Separate account assets
1,423

 
83

 
—

 
1,506

Total assets measured at fair value (1)
$
4,857

 
$
48,491

 
$
503

 
$
53,851

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
27

 
$
—

 
$
—

 
$
27

Other derivative instruments
—

 
—

 
7

 
7

GLB (2)
—

 
—

 
744

 
744

Total liabilities measured at fair value
$
27

 
$
—

 
$
751

 
$
778

(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $2,504 million and other investments of $25 million at September 30, 2015 measured using NAV. Based on new accounting guidance adopted this quarter, these investments are excluded from the hierarchy table.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB liability classified as Future policy benefits in the consolidated balance sheets. Refer to Note 5 for additional information.
 
December 31, 2014
Level 1

 
Level 2

 
Level 3

 
Total

(in millions of U.S. dollars)
 
 
 
Assets:
 
 
 
 
 
 
 
Fixed maturities available for sale
 
 
 
 
 
 
 
U.S. Treasury and agency
$
1,680

 
$
1,140

 
$
—

 
$
2,820

Foreign
—

 
15,220

 
22

 
15,242

Corporate securities
—

 
17,244

 
187

 
17,431

Mortgage-backed securities
—

 
10,271

 
15

 
10,286

States, municipalities, and political subdivisions
—

 
3,616

 
—

 
3,616

 
1,680

 
47,491

 
224

 
49,395

Equity securities
492

 
16

 
2

 
510

Short-term investments
1,183

 
1,139

 
—

 
2,322

Other investments (1)
370

 
211

 
204

 
785

Securities lending collateral
—

 
1,330

 
—

 
1,330

Investment derivative instruments
18

 
—

 
—

 
18

Other derivative instruments
—

 
2

 
—

 
2

Separate account assets
1,400

 
90

 
—

 
1,490

Total assets measured at fair value (1)
$
5,143

 
$
50,279

 
$
430

 
$
55,852

Liabilities:
 
 
 
 
 
 
 
Investment derivative instruments
$
36

 
$
—

 
$
—

 
$
36

Other derivative instruments
21

 
—

 
4

 
25

GLB (2)
—

 
—

 
406

 
406

Total liabilities measured at fair value
$
57

 
$
—

 
$
410

 
$
467


(1) 
Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $2,561 million at December 31, 2014 measured using NAV. Based on new accounting guidance adopted this quarter, these investments are excluded from the hierarchy table.
(2) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB liability classified as Future policy benefits in the consolidated balance sheets. Refer to Note 5 for additional information.
Fair Value And Maximum Future Funding Commitments Related To Investments
 
 
 
 
 
September 30

 
 
 
December 31

 
Expected
Liquidation
Period of Underlying Assets
 
 
 
2015

 
 
 
2014

(in millions of U.S. dollars)
Fair
Value

 
Maximum
Future Funding
Commitments

 
Fair
Value

 
Maximum
Future Funding
Commitments

Financial
5 to 9 Years
 
$
309

 
$
107

 
$
282

 
$
145

Real Assets
3 to 7 Years
 
473

 
168

 
451

 
210

Distressed
5 to 9 Years
 
265

 
231

 
232

 
175

Private Credit
3 to 7 Years
 
272

 
226

 
299

 
190

Traditional
3 to 9 Years
 
885

 
184

 
908

 
289

Vintage
1 to 2 Years
 
14

 
—

 
11

 
1

Investment funds
Not Applicable
 
286

 
—

 
378

 
—

 
 
 
$
2,504

 
$
916

 
$
2,561

 
$
1,010

Schedule Of Significant Unobservable Inputs Used In Level 3 Liability Valuations
(in millions of U.S. dollars, except for percentages)
Fair Value
 
Valuation
Technique
 
Significant
Unobservable Inputs
 
Ranges
September 30, 2015

 
December 31, 2014

 
 
 
GLB(1)
$
744

 
$
406

 
Actuarial model
 
Lapse rate
 
1% – 30%
 
 
 
 
 
 
 
Annuitization rate
 
0% – 55%
(1) 
Discussion of the most significant inputs used in the fair value measurement of GLB and the sensitivity of those assumptions is included within Note 4 a) Guaranteed living benefits.
Financial Instruments Measured At Fair Value Using Significant Unobservable Inputs
 
Assets
 
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

Other
investments

 
Other
derivative
instruments

GLB(1)

September 30, 2015
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance–Beginning of Period
$
56

 
$
167

 
$
55

 
$
2

$
214

 
$
3

$
347

Transfers into Level 3
1

 
2

 
—

 
—

—

 
—

—

Change in Net Unrealized Gains (Losses) included in OCI
1

 
1

 
—

 
2

(7
)
 
—

—

Net Realized Gains/Losses
(1
)
 
(1
)
 
—

 
(1
)
—

 
4

397

Purchases
—

 
22

 
—

 
1

5

 
—

—

Sales
—

 
(5
)
 
(1
)
 
—

—

 
—

—

Settlements
(4
)
 
(3
)
 
—

 
—

(3
)
 
—

—

Balance–End of Period
$
53

 
$
183

 
$
54

 
$
4

$
209

 
$
7

$
744

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
(1
)
 
$
—

 
$
—

 
$
(1
)
$
—

 
$
4

$
397

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB liability classified as Future policy benefits in the consolidated balance sheets. Refer to Note 5 for additional information.
  
Assets
 
 
Liabilities

Nine Months Ended
Available-for-Sale Debt Securities
 
 
 
 
Short-term investments

 
Other investments

 
GLB(1)

September 30, 2014
Foreign

 
Corporate
securities

 
MBS

 
Equity
securities

 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
 
Balance–Beginning of Period
$
44

 
$
166

 
$
8

 
$
4

 
$
7

 
$
196

 
$
193

Transfers into Level 3
3

 
35

 
—

 
—

 
—

 
—

 
—

Transfers out of Level 3
(34
)
 
(22
)
 
—

 
(2
)
 
(7
)
 
—

 
—

Change in Net Unrealized Gains (Losses) included in OCI
(1
)
 
1

 
—

 
1

 
—

 
1

 
—

Net Realized Gains/Losses
1

 
2

 
—

 
—

 
—

 
—

 
124

Purchases
2

 
65

 
8

 
1

 
—

 
15

 
—

Sales
(3
)
 
(17
)
 
—

 
(2
)
 
—

 
—

 
—

Settlements
—

 
(22
)
 
(1
)
 
—

 
—

 
(7
)
 
—

Balance–End of Period
$
12

 
$
208

 
$
15

 
$
2

 
$
—

 
$
205

 
$
317

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
124

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB liability classified as Future policy benefits in the consolidated balance sheets. The liability for GLB reinsurance was $566 million at September 30, 2014 and $427 million at December 31, 2013, which includes a fair value derivative adjustment of $317 million and $193 million, respectively.
 
 
 
 
 
 
 
 
Assets

 
 
Liabilities

Nine Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

Other
investments

 
Other
derivative
instruments

GLB(1)

September 30, 2015
Foreign

 
Corporate
securities

 
MBS

 
 
(in millions of U.S. dollars)
 
 
 
 
Balance–Beginning of Period
$
22

 
$
187

 
$
15

 
$
2

$
204

 
4

$
406

Transfers into Level 3
29

 
15

 
—

 
—

—

 
—

—

Change in Net Unrealized Gains (Losses) included in OCI
(1
)
 
1

 
—

 
2

(7
)
 
—

—

Net Realized Gains/Losses
(1
)
 
(4
)
 
—

 
(2
)
—

 
3

338

Purchases
9

 
38

 
41

 
2

21

 
—

—

Sales
(1
)
 
(10
)
 
(1
)
 
—

—

 
—

—

Settlements
(4
)
 
(44
)
 
(1
)
 
—

(9
)
 
—

—

Balance–End of Period
$
53

 
$
183

 
$
54

 
$
4

$
209

 
$
7

$
744

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
(1
)
 
$
(2
)
 
$
—

 
$
(2
)
$
—

 
$
3

$
338

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB liability classified as Future policy benefits in the consolidated balance sheets. Refer to Note 5 for additional information.
  
Assets
 
 
Liabilities

Three Months Ended
Available-for-Sale Debt Securities
 
 
Equity
securities

 
Other
investments

 
GLB(1)

September 30, 2014
Foreign

 
Corporate
securities

 
MBS

 
 
 
(in millions of U.S. dollars)
 
 
 
 
 
Balance–Beginning of Period
$
12

 
$
204

 
$
7

 
$
2

 
$
203

 
$
241

Transfers into Level 3
1

 
5

 
—

 
—

 
—

 
—

Change in Net Unrealized Gains (Losses) included in OCI
—

 
(1
)
 
—

 
—

 
(1
)
 
—

Net Realized Gains/Losses
—

 
2

 
—

 
—

 
—

 
76

Purchases
—

 
20

 
8

 
—

 
6

 
—

Sales
(1
)
 
(9
)
 
—

 
—

 
—

 
—

Settlements
—

 
(13
)
 
—

 
—

 
(3
)
 
—

Balance–End of Period
$
12

 
$
208

 
$
15

 
$
2

 
$
205

 
$
317

Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
76

(1) 
Our GLB reinsurance product meets the definition of a derivative instrument for accounting purposes and is accordingly carried at fair value. Excluded from the table above is the portion of the GLB liability classified as Future policy benefits in the consolidated balance sheets. The liability for GLB reinsurance was $566 million at September 30, 2014, and $486 million at June 30, 2014, which includes a fair value derivative adjustment of $317 million and $241 million, respectively.

Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value
September 30, 2015
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
599

 
$
175

 
$
—

 
$
774

 
$
756

Foreign
—

 
818

 
—

 
818

 
784

Corporate securities
—

 
3,112

 
14

 
3,126

 
3,093

Mortgage-backed securities
—

 
1,817

 
—

 
1,817

 
1,758

States, municipalities, and political subdivisions
—

 
2,215

 
—

 
2,215

 
2,173

Total assets
$
599

 
$
8,137

 
$
14

 
$
8,750

 
$
8,564

Liabilities:
 
 
 
 
 
 
 
 
 
Short-term debt
$
—

 
$
2,105

 
$
—

 
$
2,105

 
$
2,103

Long-term debt
—

 
4,376

 
—

 
4,376

 
4,157

Trust preferred securities
—

 
457

 
—

 
457

 
309

Total liabilities
$
—

 
$
6,938

 
$
—

 
$
6,938

 
$
6,569


December 31, 2014
Fair Value
 
 
Carrying Value

(in millions of U.S. dollars)
Level 1

 
Level 2

 
Level 3

 
Total

 
Assets:
 
 
 
 
 
 
 
 
 
Fixed maturities held to maturity
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency
$
659

 
$
191

 
$
—

 
$
850

 
$
832

Foreign
—

 
963

 
—

 
963

 
916

Corporate securities
—

 
2,408

 
15

 
2,423

 
2,323

Mortgage-backed securities
—

 
2,039

 
—

 
2,039

 
1,983

States, municipalities, and political subdivisions
—

 
1,314

 
—

 
1,314

 
1,277

Total assets
$
659


$
6,915


$
15


$
7,589


$
7,331

Liabilities:
 
 
 
 
 
 
 
 
 
Short-term debt
$
—

 
$
2,571

 
$
—

 
$
2,571

 
$
2,552

Long-term debt
—

 
3,690

 
—

 
3,690

 
3,357

Trust preferred securities
—

 
462

 
—

 
462

 
309

Total liabilities
$
—

 
$
6,723

 
$
—

 
$
6,723

 
$
6,218